For over 20 years biolitec® has been working closely with leading physicians and medical institutions all over the world to improve minimally invasive laser therapies.

Physicians, who have been using the biolitec® laser therapies for years, are an important part in the company's product developments. A lot of physicians are conducting medical studies and trials in which long-term effects of the biolitec® therapies are analyzed.
 

Now we would like to present to you the latest results and invite you to contact us to share your experiences and discuss them with us.

LIFE for Benign Prostate Hyperplasia


March 2019:
Leonardi, Rosario: "The LEST technique: Treatment of prostatic obstruction preserving antegrade ejaculation in patients with benign prostatic hyperplasia", in: Archivio Italiano Di Urologia E Andrologia 2019, 91(1), 35-42. https://doi.org/10.4081/aiua.2019.1.35

June 2017:
Miyazaki, Hideyo et al: "Early Experiences of Contact Laser Vaporization of the Prostate using the 980 nm High Power Diode Laser for Benign Prostatic Hyperplasia", in: Lower Urinary Tract Symptoms 2017, 10: 242-246. https://doi.org/10.1111/luts.12173

XCAVATOR_R__fiber_by_biolitec_R__high_res
biolitec® XCAVATOR® laser fiber with more rounded angles for higher ablation rate and smoother movement on the tissue
xcavator-badge_en

TULA® – Trans Urethral Laser Ablation of Recurring Bladder Tumors


September 2022:
Pedersen, Gyrithe Lynghøj et al.: "Outpatient Photodynamic Diagnosis–guided Laser Destruction of Bladder Tumors Is as Good as Conventional Inpatient Photodynamic Diagnosis–guided Transurethral Tumor Resection in Patients with Recurrent Intermediate-risk Low-grade Ta Bladder Tumors. A Prospective Randomized Noninferiority Clinical Trial", in: European Urology 2022. In press, but available online https://doi.org/10.1016/j.eururo.2022.08.012

October 2020:
Agrawal, S. et al: "Outpatient Transurethral Laser Ablation for Urothelial Cancer - A safe alternative to TURPT in the era of Covid-19", Poster for 40th Congress of the Société Internationale d'Urologie (SIU) in October 2020 [read]

April 2018:
Hermann G. G. et al: "Outpatient diode laser treatment of intermediate-risk non-invasive bladder tumors without sedation: efficacy, safety and economic analysis", in: Scandinavian Journal of Urology 2018, Vol 52, Issue 3, pages 194-198. https://doi.org/10.1080/21681805.2018.1450782

 

Removal_of_non-invasive_bladder_tumors_with_the_TULA_R__laser_therapy_of_biolitec_R____c__biolitec_R__
Removal of non-invasive bladder tumors with the special TULA® laser fiber of biolitec®
Holmium_fiber_400_um_flat_tip_by__biolitec_R__for_tumor_treatment_Ausschnitt_web
Atraumatic fiber tip by biolitec® for bladder tumor treatment

biolitec®

Otto-Schott-Str. 15
07745 Jena
Germany

Tel: 
+49 (0) 3641 519 53 0
Fax: 
+49 (0) 3641 519 53 33

E-Mail: 
info[at]biolitec.de
Internet: 
www.biolitec.com

biolitec® Apps
download here!

AppStores_ohne_Hintergrund